2024-06-11T08:08:38-05:00 2023-06-30 520982413 GROSS MENDELSOHN & ASSOCIATES PA 1801 PORTER STREET SUITE 500 BALTIMORE MD 21230 990 2022-07-01 366212451 BIOMEDICAL ENGINEERING SOCIETY BIOM 3014591999 8201 CORPORATE DRIVE 1125 LANDOVER MD 207852224 JOHN FALCIONI EXECUTIVE DIRECTOR 3014591999 2024-06-11 1 JOHN FALCIONI 999000999 1 JENNIFER ROCK P01083312 4106855512 2024-06-01 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z X JOHN FALCIONI 8201 CORPORATE DRIVE 1125 LANDOVER MD 207852224 5754967 0 X WWW.BMES.ORG X 1968 MD TO ENCOURAGE DEVELOPMENT, INTEGRATION, AND UTILIZATION OF KNOWLEDGE IN THE BIOMEDICAL ENGINEERING FIELD. 20 20 11 140 0 0 862543 452728 1528475 2589852 337286 205275 313713 334934 3042017 3582789 52254 22250 0 0 1040417 946558 0 0 0 1739022 1869215 2831693 2838023 210324 744766 4408175 5517133 795652 1119234 3612523 4397899 X TO BUILD AND SUPPORT THE BIOMEDICAL ENGINEERING COMMUNITY (LOCALLY, NATIONALLY, AND INTERNATIONALLY) WITH ACTIVITIES DESIGNED TO COMMUNICATE RECENT ADVANCES, DISCOVERIES, AND INVENTIONS; TO PROMOTE EDUCATION AND PROFESSIONAL DEVELOPMENT; AND INTEGRATE THE PERSPECTIVES OF THE ACADEMIC, MEDICAL, GOVERNMENTAL, AND BUSINESS SECTORS. THE BIOMEDICAL ENGINEERING SOCIETY PROMOTES A COLLABORATIVE AND INCLUSIVE COMMUNITY TO ADVANCE HUMAN HEALTH THROUGH EDUCATION, DISCOVERY AND TRANSLATION. 0 0 954905 0 2345213 ANNUAL MEETING: BIOMEDICAL ENGINEERING SOCIETY CONTINUED THE TRADITION OFFERING AN EXCELLENT TECHNICAL CONTENT AND A MEETING ENVIRONMENT THAT OFFERED MANY OPPORTUNITIES FOR DISCUSSION AND SOCIAL INTERACTION. HIGHLIGHTS OF THE MEETING INCLUDED TOPICS ON ARTIFICIAL ORGANS, CARDIOVASCULAR SYSTEM, BIOMATERIALS, CELLULAR ENGINEERING, NEURAL ENGINEERING, BIOMECHANICS,TISSUE ENGINEERING, JOB FAIR AND EXHIBITION. 184299 244639 SPECIAL INTEREST GROUPS: THE ORGANIZATION HAS ESTABLISHED A PROCESS FOR MEMBERS OF THE SOCIETY WHO HAVE AN INTEREST IN FORMING SPECIAL INTEREST GROUPS (SIGS). THE PURPOSE OF SIGS ARE TO PROVIDE NETWORKING OPPORTUNITIES FOR THE EXCHANGE OF INFORMATION AND IDEAS IN A SPECIFIC RESEARCH AREA, TO PROVIDE MEMBERS WITH A FORUM TO NETWORK AND DISCUSS ISSUES RELEVANT TO THIS RESEARCH AREA, TO PROVIDE THE SOCIETY WITH A DIRECT AVENUE TO MEMBERS WITH SPECIFIC EXPERTISE AND TO PROVIDE MEMBERS WITH AN AVENUE FOR PROFESSIONAL DEVELOPMENT WITHIN A SPECIFIC RESEARCH AREA. 951847 MEMBERSHIP: THE MEMBERSHIP CONSISTED OF A WIDE VARIETY OF PROFESSIONALS AND LEADERS THAT WERE HELPFUL IN THE PROFESSIONAL DEVELOPMENT AND CONTRIBUTED TO THE PURSUIT OF EXCELLENCE IN THE FIELD OF BIOMEDICAL ENGINEERING. THERE ARE SEVERAL CATEGORIES OF MEMBERSHIP; REGULAR MEMBERS, ASSOCIATE MEMBERS, STUDENT MEMBERS, EMERITIS MEMBERS, AND CORPORATE MEMBERS. BMES PUBLISHES A MONTHLY PEER-REVIEWED SCIENTIFIC JOURNAL WHICH IS INCLUDED IN THE MEMBERSHIP FEE OF REGULAR MEMBERS. BMES PUBLISHES FOUR PEER-REVIEWED SCIENTIFIC JOURNALS WHICH ARE INCLUDED AS PART OF MEMBERSHIP DUES: ANNALS OF BIOMEDICAL ENGINEERING, CELULAR AND MOLECULAR BIOENGINEERING, CARDIOVASCULAR ENGINEERNIG & TECHNOLOGY, AND BIOMEDICAL ENGINEERING EDUCATION. 22250 4024 22250 4024 2091051 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 55 0 1 11 1 0 0 0 0 0 0 0 0 0 0 0 0 X 20 20 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 0 1 1 0 MD X X JOHN FALCIONI 3014591999 8201 CORPORATE DRIVE LANDOVER MD 207852224 X CHARITY QUICK-BORGARD EXECUTIVE DIRECTOR & CEO (FORMER) 40.00 X 251580 0 45208 JOHN FALCIONI EXECUTIVE DIRECTOR & CEO 40.00 X X 0 0 0 CYNTHIA A KING PRESIDENT 2.00 X X 0 0 0 TREENA LYNNE ARINZEH PHD SECRETARY 2.00 X X 0 0 0 DEBRA AUGUSTE PHD TREASURER 2.00 X X 0 0 0 JOHN WHITE PAST PRESIDENT 1.00 X 0 0 0 STEVEN C GEORGE BOARD MEMBER 1.00 X 0 0 0 DONALD P GAVER PHD BOARD MEMBER 1.00 X 0 0 0 JENNY AMOS PHD BOARD MEMBER 1.00 X 0 0 0 STEPHANIE KLADAKIS PHD BOARD MEMBER 1.00 X 0 0 0 ROSS ETHIER PHD BOARD MEMBER 1.00 X 0 0 0 KENT LEACH PHD BOARD MEMBER 1.00 X 0 0 0 DAVID JAMISON PHD BOARD MEMBER 1.00 X 0 0 0 SANJAY KUMAR MD PHD BOARD MEMBER 1.00 X 0 0 0 RUTH OCHIA PHD BOARD MEMBER 1.00 X 0 0 0 MANU PLATT PHD BOARD MEMBER 1.00 X 0 0 0 TAMARA BAYNHAM BOARD MEMBER 1.00 X 0 0 0 GUOHAO DAI BOARD MEMBER 1.00 X 0 0 0 BRENDAN HARLEY BOARD MEMBER 1.00 X 0 0 0 ELIZABETH COSGRIFF-HERNANDEZ BOARD MEMBER 1.00 X 0 0 0 LORI SETTON BOARD MEMBER 1.00 X 0 0 0 251580 0 45208 1 1 1 0 0 451980 748 452728 ANNUAL MEETING 900099 2345213 2345213 SPECIAL INTEREST GROUPS 900099 244639 244639 2589852 127395 127395 330910 330910 2250058 2172178 77880 77880 77880 MISCELLANEOUS 900099 4024 4024 4024 3582789 2593876 0 536185 X 22250 22250 394858 197429 197429 406537 339462 67075 40658 31282 9376 46970 35375 11595 57535 39060 18475 7423 7423 64019 64019 19429 19429 19906 9262 10644 2578 2500 78 207183 61131 146052 112013 76045 35968 26065 1090 24975 954905 954905 3828 3828 6007 4078 1929 SPECIAL INTEREST GROUPS 184299 184299 STIPENDS 126000 47000 79000 TEMPORARY HELP 83534 50034 33500 STUDENT CHAPTER SUPPORT 21000 21000 31026 14849 16177 2838023 2091051 746972 0 X 240264 877116 9521 54095 0 360427 213652 99816 86849 10204 12967 3781942 4160021 5817 199282 4408175 5517133 94935 130224 676263 782158 24454 206852 795652 1119234 X 2090704 2882173 1521819 1515726 3612523 4397899 4408175 5517133 744766 40610 0 X X 0 1 X 1 0 X 618886 644082 571885 862543 452728 3150124 2828613 2515653 906320 1528475 2589852 10368913 3447499 3159735 1478205 2391018 3042580 13519037 0 0 0 13519037 333866 450254 459778 483916 458305 2186119 333866 450254 459778 483916 458305 2186119 12203 4220 4024 20447 3781365 3609989 1950186 2879154 3504909 15725603 0.85970 0.86380 0.13900 0.13510 X 612184 23474 20170 615488 700379 -76195 12000 612184 611156 30000 76728 17505 700379 584066 25200 19021 17131 611156 572021 29264 17219 584066 0.08440 0.71980 0.19580 0 0 85018 72051 12967 14798 14798 0 12967 OPERATING LEASE LIABILITIES 206852 206852 X 3603970 40610 40610 3563360 19429 19429 3582789 2818594 0 2818594 19429 19429 2838023 PART X, LINE 2: THE SOCIETY HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE (IRS) AS A TAX-EXEMPT ORGANIZATION, AS DEFINED BY SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC), THAT IS PUBLICLY SUPPORTED AND, THEREFORE, NOT A PRIVATE FOUNDATION. INCOME THAT IS NOT RELATED TO EXEMPT PURPOSES, LESS APPLICABLE DEDUCTIONS, IS SUBJECT TO FEDERAL AND STATE INCOME TAXES. THE SOCIETY HAD NO UNRELATED BUSINESS INCOME FOR THE YEARS ENDED JUNE 30, 2023 AND 2022. ACCORDINGLY, NO PROVISION FOR INCOME TAXES IS REFLECTED IN THESE FINANCIAL STATEMENTS. THE SOCIETY'S FEDERAL EXEMPT ORGANIZATION TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE IRS, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THE RETURNS ARE FILED. 1 AWARDS 8 22250 FORM 990, SCHEDULE I, PART III THE ORGANIZATION HAS AN AWARD COMMITTEE TO SUPERVISE THE PROCESS OF AWARD. THE ORGANIZATION'S STAFF SUBMITS NOMINATION OF AWARD RECIPIENTS TO THE AWARD COMMITTEE. THE COMMITTEE REVIEWS AND DETERMINES IF THE NOMINEES MEET RELATED CRITERIA. X 0 1 0 0 0 0 0 0 0 CHARITY QUICK-BORGARD EXECUTIVE DIRECTOR & CEO (FORMER) 251580 0 0 0 0 0 25712 0 19496 0 296788 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE EXECUTIVE DIRECTOR AND DIRECTOR OF FINANCE PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C DISCLOSURE FORM IS DISTRIBUTED AT BOARD MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMMITTEE DETERMINES THE COMPENSATION OF THE EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST PART IX, LINE 18 BIOMEDICAL ENGINEERING SOCIETY HAS AMENDED THEIR 2022 FORM 990 TO PROPERLY REPORT TOTAL EXPENSES FOR THE YEAR ENDED 06/30/23 AS FOLLOWS: PAYMENTS OF TRAVEL OR ENTERTAINMENT: ORIGINALLY REPORTED - $989,905 AMENDED - $954,905 PART IX, LINE 24B BIOMEDICAL ENGINEERING SOCIETY HAS AMENDED THEIR 2022 FORM 990 TO PROPERLY REPORT TOTAL EXPENSES FOR THE YEAR ENDED 06/30/23 AS FOLLOWS: STIPENDS: ORIGINALLY REPORTED - $141,000 AMENDED - $126,000 PART X, LINE 32 BIOMEDICAL ENGINEERING SOCIETY HAS AMENDED THEIR 2022 FORM 990 TO PROPERLY REPORT TOTAL NET ASSETS AT 06/30/23 AS FOLLOWS: TOTAL NET ASSETS: ORIGINALLY REPORTED - $4,347,899 AMENDED - $4,397,899 FORM 990, PART XII, LINE 2C: THE BOARD OF DIRECTORS ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT.